Cipla Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "Press Release ‐ Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA".